8-Br-cGMP is superior to prostaglandin E1 for lung preservation

Annals of Thoracic Surgery

Volumn 68, Issue 4, 1999, Pages 1138-1142

  Hillinger, Sven ^a   Schmid, Ralph A ^a   Sandera, Peter ^a   Stammberger, Uz ^a   Schneiter, Dieter ^a   Schoedon, Gabriele ^a   Weder, Walter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC GMP; DEXTRAN; MYELOPEROXIDASE; PROSTAGLANDIN E1; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; INTRAARTERIAL DRUG ADMINISTRATION; ISCHEMIA; LIPID PEROXIDATION; LUNG EDEMA; LUNG TRANSPLANTATION; NEUTROPHIL; NONHUMAN; ORGAN PRESERVATION; PRIORITY JOURNAL; PULMONARY ARTERY; REPERFUSION INJURY; SWINE;

EID: 0032695517     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00981-9     Document Type: Conference Paper

References (24)

1. Novick R.J., Gehman K.E., Ali I.S., Lee J. Lung preservation the importance of endothelial and alveolar type II cell integrity . Ann Thorac Surg. 62:1996;302-314.
2. Date H., Triantafillou A.N., Trulock E.P., Pohl M.S., Cooper J.D., Patterson G.A. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg. 111:1996;913-919.
3. Yamashita M., Schmid R.A., Ando K., Cooper J.D., Patterson G.A. Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg. 62:1996;791-797.
4. Shiraishi Y., Lee J.R., Laks H., et al. L-arginine administration during reperfusion improves pulmonary function. Ann Thorac Surg. 62:1996;1580-1587.
5. Schmid RA, Hillinger S, Walter R, et al. The nitric oxide synthase cofactor tetrahydrobiopterin reduces allograft ischemia/reperfusion injury following lung transplantation. J Thorac Cardiovasc Surg 1999; (in press).
6. Pinsky D.J., Naka Y., Chodhury N.C., et al. The nitric oxide/cyclic GMP pathway in organ transplantation a critical role in successful lung preservation . Proc Natl Acad Sci USA. 91:1994;12086-12090.
7. Schmid R.A., Zollinger A., Singer T., et al. Effect of soluble complement receptor type 1 (sCR1) on reperfusion edema and neutrophil migration following lung allotransplantation in swine. J Thorac Cardiovasc Surg. 116:1998;90-97.
8. Hachenberg T., Tenling A., Rothen H.U., Nyström S.O., Tyden H., Hedenstierna G. Thoracic intravascular and extravascular fluid volumes in cardiac surgical patients. Anesthesiology. 79:1993;976-984.
9. Kirk A.J., Colquhoun I.W., Dark J.H. Lung preservation a review of current practice and future directions . Ann Thorac Surg. 56:1993;990-1000.
10. Naka Y., Roy D.K., Liao H., et al. cAMP-mediated vascular protection in an orthotopic rat lung transplant model. Insights into the mechanism of action of prostaglandin E1 to improve lung preservation. Circ Res. 79:1996;773-783.
11. Aoe M., Trachiotis G.D., Okabayashi K., et al. Administration of prostaglandin E1 after lung transplantation improves early graft function. Ann Thorac Surg. 58:1994;655-661.
12. Kukkonen S., Heikkila L.J., Verkkala K., Mattila S.P., Toivonen H. Prostaglandin E1 or prostacyclin in Euro-Collins solution fails to improve lung preservation. Ann Thorac Surg. 60:1995;1617-1622.
13. Bonser R.S., Fragomeni L.S., Jamieson S.W., et al. Effects of prostaglandin E1 in twelve-hour lung preservation. J Heart Lung Transplant. 10:1991;310-316.
14. Bhabra M.S., Hopkinson D.N., Shaw T.E., Hooper T.L. Relative importance of prostaglandin/cyclic adenosine monophosphate and nitric oxide/cyclic guanosine monophosphate pathways in lung preservation. Ann Thorac Surg. 1996;1494-1499.
15. Arnal J.F., Münzel T.H., Venema R.C., James N.L., Bai C., Mitch W.E. Interactions between L-arginine and L-glutamine change endothelial NO production. J Clin Invest. 95:1995;2565-2572.
16. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite implications for endothelial injury from nitric oxide and superoxide . Proc Natl Acad Sci USA. 87:1990;1620-1624.
17. Chintala M.S., Bernardino V., Chiu P.J.S. Cyclic GMP but not cyclic AMP prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats. J Pharmacol Exp Ther. 271:1994;1203-1208.
18. Chetham P.M., Sefton W.D., Bridges J.P., Stevens T., McMurtry I.F. Inhaled nitric oxide pretreatment but not posttreatment attenuates ischemia/reperfusion-induced pulmonary microvascular leak. Anesthesiology. 86:1997;895-902.
19. King R.C., Laubach V.E., Kanithanon R.C., et al. Preservation with 8-Bromo-cyclic GMP improves pulmonary function after prolonged ischemia. Ann Thorac Surg. 66:1998;1732-1738.
20. Naka Y., Roy D.K., Smerling A.J., et al. Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. J Thorac Cardiovasc Surg. 110:1995;1434-1441.
21. Wang G.R., Zhu Y., Halushka P.V., Lincoln T.M., Mendelsohn M.E. Mechanism of platelet inhibition by nitric oxide In vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase . Proc Natl Acad Sci USA. 95:1998;4888-4893.
22. Lawson C.A., Smerling A.J., Naka Y., et al. Selective reduction of PVR by inhalation of a cGMP analogue in a porcine model of pulmonary hypertension. Am J Physiol. 37:1995;H2056-H2062.
23. Sakamaki F., Hoffmann H., Mueller C., Dienemann H., Messmer K., Schildberg F.W. Reduced lipid peroxidation and ischemia-reperfusion injury after lung transplantation using low-potassium dextran solution for lung preservation. Am J Respir Crit Care Med. 156:1997;1073-1081.
24. 1 and temperature on lung function following preservation. Transplantation. 52:1991;626-630.